Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-01-08 06:10 am Sale | 13D | China Biologic Products Inc. CBPO | PW Medtech Group Ltd | 0 0.000% | -3,750,000 (Position Closed) | View |
2020-12-31 06:13 am Sale | 13D | China Biologic Products Inc. CBPO | PW Medtech Group Ltd | 3,750,000 9.700% | -1,571,000 (-29.52%) | View |
2020-11-20 08:54 am Unchanged | 13D | China Biologic Products Inc. CBPO | PW Medtech Group Ltd | 5,321,000 13.700% | 0 (Unchanged) | View |
2020-10-28 08:53 am Unchanged | 13D | China Biologic Products Inc. CBPO | PW Medtech Group Ltd | 5,321,000 13.800% | 0 (Unchanged) | View |
2020-09-17 08:57 am Unchanged | 13D | China Biologic Products Inc. CBPO | PW Medtech Group Ltd | 5,321,000 13.800% | 0 (Unchanged) | View |
2020-05-11 08:00 am Sale | 13D | China Biologic Products Inc. CBPO | PW Medtech Group Ltd | 5,321,000 13.800% | -1,000,000 (-15.82%) | View |
2020-05-05 08:50 am Unchanged | 13D | China Biologic Products Inc. CBPO | PW Medtech Group Ltd | 6,321,000 16.430% | 0 (Unchanged) | View |
2020-03-20 08:00 am Unchanged | 13D | China Biologic Products Inc. CBPO | PW Medtech Group Ltd | 6,321,000 16.430% | 0 (Unchanged) | View |
2020-01-24 08:00 am Unchanged | 13D | China Biologic Products Inc. CBPO | PW Medtech Group Ltd | 6,321,000 16.440% | 0 (Unchanged) | View |